Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A0LD6E6
Mon, 16.12.2024
Gerresheimer AG
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
Innovative combination product of furosemide and on-body device
Ready-to-market device designed, developed and manufactured by Gerresheimer
Patented device technology for precise administration
Düsseldorf, Germany, December 16, 2024. Gerresheimer, an innovative system a [ … ]
Wed, 11.12.2024
Gerresheimer AG
Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group
Complementary product portfolio and broad footprint of production sites in Europe
Strengthening the market position as a full-service provider for the pharma and biotech industry
Strategic reset of Moulded Glass business
Düsseldo [ … ]
Mon, 02.12.2024
Gerresheimer AG
Gerresheimer builds new production capacities for glass syringes at Skopje site
Expansion of the site in the Republic of North Macedonia with a new production hall for glass syringes
Total investment volume of over EUR 100 million
Around 250 new jobs for skilled workers from the region
Ramp-up of syringe production starting by the end of 2024
[ … ]
Mon, 14.10.2024
Gerresheimer AG
Solar power for Gerresheimer site in Momignies, Belgium
2.3 MWp rooftop photovoltaic system on production building
Gerresheimer increases share of green electricity in its energy supply
Goal for 2030: 100% electricity from renewable sources
Duesseldorf/Momignies, October 14, 2024. Gerresheimer, an innovative system and solution partner and a glo [ … ]
Thu, 26.09.2024
Gerresheimer AG
Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU”
Market advances adoption of ready-to-use containers
Improved operational efficiency in pharmaceutical manufacturing processes
Increased patient safety with high-quality sterile primary packaging
Düsseldorf, September 26, 2024. Gerresheimer AG (MDAX: G [ … ]
Mon, 16.09.2024
Gerresheimer AG
Gerresheimer: EcoVadis Gold with further improved score
Gerresheimer among the top 3 % of all rated companies
Overall result increased to 76/100 points
Award underlines consistent implementation of the sustainability strategy
Düsseldorf, September 16, 2024 - Gerresheimer, an innovative systems and solutions provider and global partner for the ph [ … ]
Mon, 16.09.2024
Gerresheimer AG
Gerresheimer: EcoVadis Gold with further improved score
Gerresheimer among the top 3 % of all rated companies
Overall result increased to 76/100 points
Award underlines consistent implementation of the sustainability strategy
Düsseldorf, September 16, 2024 - Gerresheimer, an innovative systems and solutions provider and global partner for the ph [ … ]
Thu, 11.07.2024
Gerresheimer AG
Gerresheimer remains on track in 1st half year 2024
Organic growth: revenues +1.7%, adjusted EBITDA +2.9%
Plastics & Devices division with good revenue growth and significantly improved margin
Guidance confirmed
Düsseldorf (Germany), July 11, 2024. Gerresheimer, an innovative systems & solutions provider and global partner for the pharma [ … ]
Mon, 27.05.2024
Gerresheimer AG
Gerresheimer expands capacities for Medical Systems in the USA
Two-stage expansion of the Peachtree City, Georgia site
Total investment volume of around USD 180 million
More than 400 new jobs for skilled workers from the region
Ramp-up of production beginning end of 2024
Düsseldorf / Peachtree City, USA, May 27, 2024 – Gerresheimer, an innovati [ … ]
Thu, 23.05.2024
Gerresheimer AG
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
Strategic acquisition: Complementary product portfolio and broad footprint with production sites in Europe
Gerresheimer underpins leading market position as a full-service provider for the pharmaceutical and biote [ … ]